Prof. Zhengyin Liao 廖正银
Chief Physician, Professor
Department of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive interventional therapies.
Dr. Liao is a Professor and Master’s supervisor at West China Hospital, Sichuan University. Dr. Liao holds a medical doctorate from Sichuan University and completed postdoctoral training in minimally invasive interventional therapy at Beijing 301 Hospital. Dr. Liao has published over 30 articles, participated in national and provincial research projects, and presented on minimally invasive tumor treatments at international conferences.
Professional roles
- Member, Chinese Medical Association
- Deputy Leader, Minimally Invasive Interventional Group, Pain Society of the Chinese Medical Association
- Member, Tumor Minimally Invasive Therapy Professional Committee, China Anti-Cancer Association
- Editorial Board Member, Chinese Journal of Interventional Imaging and Therapeutics
Name order: in Chinese the family name comes first (Liao Zhengyin). Papers usually list the name as Zhengyin Liao or Liao Z.
Selected publications
27 papers on PubMed matched by name and affiliation; 11 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Biosci (Landmark Ed), 2022 (senior author): Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer. PubMed 35866399
- J Vasc Surg Venous Lymphat Disord, 2022 (senior author): Efficiency and safety of ethanol sclerotherapy for labial arteriovenous malformations. PubMed 34774812
- Future Oncol, 2021 (senior author): Progress and prospects of immune checkpoint inhibitors in advanced gastric cancer. PubMed 33397136
- Front Oncol, 2021 (senior author): Biomarkers in Immunotherapy-Based Precision Treatments of Digestive System Tumors. PubMed 33777812
- Oncol Lett, 2020 (senior author): Current progress and prospect of immune checkpoint inhibitors in hepatocellular carcinoma. PubMed 32802167
- Clin Otolaryngol, 2020 (senior author): Percutaneous ethanol sclerotherapy for auricular arteriovenous malformation: Our experience with 11 patients. PubMed 32385948
- Hepatol Int, 2018 (senior author): Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. PubMed 30073454
- BMC Cancer, 2018 (senior author): Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus. PubMed 29378532
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion